You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Momentous - that's how one leading UK dementia charity described the approval of the Alzheimer's drug lecanemab back in August 2024.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.